Bonus Episode: Emerging Treatments in Atopic Dermatitis

This episode, sponsored by an educational grant from Sanofi Genzyme and Regeneron, is the fourth instalment in a five-part series exploring the subject of atopic dermatitis (AD). Hear from Dr Chih-Ho Hong, Dermatologist, and Dr Peter Lio, Clinical Assistant Professor, Northwestern University, Feinberg School of Medicine, who explore the roles of dupilumab versus emerging Janus kinase (JAK) inhibitor therapies in children, adolescents, and adults with moderate-to-severe AD.